Industry Research Reports

The global market for Helicobacter Pylori Screening Test was estimated to be worth US$ 480 million in 2024 and is forecast to a readjusted size of US$ 653 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

The global market for Helicobacter Pylori Screening Test was valued at US$ 480 million in the year 2024 and is projected to reach a revised size of US$ 653 million by 2031, growing at a CAGR of 4.5% during the forecast period.

The global Helicobacter Pylori Screening Test market is projected to grow from US$ 480 million in 2024 to US$ 653 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.

The global Helicobacter Pylori Screening Test market size was US$ 480 million in 2024 and is forecast to a readjusted size of US$ 653 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

The global Animal Hospitals and Veterinary Clinics Services market is projected to grow from US$ 11400 million in 2024 to US$ 20540 million by 2031, at a CAGR of 8.9% (2025-2031), driven by critical product segments and diverse end‑use applications.

The global DNA Synthesis market is projected to grow from US$ 1401 million in 2024 to US$ 3410 million by 2031, at a CAGR of 13.6% (2025-2031), driven by critical product segments and diverse end‑use applications.

The global Leukemia Molecular Diagnostics market is projected to grow from US$ 2115 million in 2024 to US$ 4175 million by 2031, at a CAGR of 10.4% (2025-2031), driven by critical product segments and diverse end‑use applications.

The global LFA-based Cardiac Marker market is projected to grow from US$ 3839 million in 2024 to US$ 5853 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications.

The global Musculoskeletal System Disorder market is projected to grow from US$ 152 million in 2024 to US$ 202 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

The global Biologics Fill-Finish Services market is projected to grow from US$ 2037 million in 2024 to US$ 3046 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications.